How much does a box of Acalabrutinib cost?

Acalabrutinib (Acalabrutinib) is a new generation of oral small molecule targeted drugs, which belongs to the brutenib (BTK) inhibitor class. BTK is a key protein in the B cell receptor signaling pathway, and its abnormal activation is related to BCellular malignant lesions, especially chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are related. Acotinib selectively inhibits BTK activity and blocks B cell signaling, thereby slowing or stopping the growth of cancer cells.

Acotinib has been launched in China, but it has not yet been included in medical insurance. Since it has just been launched, it is still difficult for patients to purchase it domestically. They need to purchase acotinib through overseas channels. The cheaper ones abroad are mainly generic drugs, mainly Bangladeshi generic drugs. The price is around 6,000 to 7,000, and the ingredients of original drugs and generic drugs are basically the same.

Compared with traditionalBTK inhibitors, acotinib is more selective, reduces inhibition of other proteins, and reduces the incidence of adverse reactions. This characteristic makes acotinib a promising new drug for the treatment of B B cell malignant lesions such as CLL/SLL.

Clinical trial results show that acotinib has achieved significant efficacy in the treatment ofCLL/SLL patients. Patients often show high tolerability and good quality of life after taking acotinib. In addition, acotinib has also shown potential efficacy in the treatment of other B cell-related diseases.

However, as a drug, acotinib also has certain adverse reactions and risks, including but not limited to high blood pressure, headache, muscle pain, etc. Therefore, when using acotinib, doctors need to comprehensively consider the patient's specific situation and develop an individualized treatment plan.